Overview

Clinical Assessment of Itraconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel

Status:
Completed
Trial end date:
2018-06-30
Target enrollment:
0
Participant gender:
All
Summary
Clinical study for the developed Itraconazole self nano emulsifying drug delivery system intermediate gel was conducted on 30 patients with tinea versicolor infection.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Sara Botros
Treatments:
Hydroxyitraconazole
Itraconazole
Criteria
Inclusion Criteria:

- Tinea Versicolor infection

Exclusion Criteria:

- concomitant treatment with other medications for the same condition being studied,
TVC.

- pregnancy

- lactation

- immunocompromised patients